🇺🇸 Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets. in United States

Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets. (Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets.) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets. in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets. approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Jinsang Liyan Capsule; Rabeprazole enteric-coated tablets. in United States?

Tongji Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.